Empfehlungen zur Malariaprophylaxe

Key words

travel medicine - malaria - repellents - chemoprophylaxis - pediatric travelers - pregnant travelers

Publication History

Article published online:
11 August 2022

• Literatur

• 1 World Health Organization. World Malaria Report 2021. Geneva: WHO; 2021
• 2 Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch für 2020. Berlin; 2021
• 3 Falkenhorst G.. Persönliche Kommunikation. 2022
• 4 Schlabe S, Reiter-Owona I, Nordmann T. et al Rapid diagnostic test negative Plasmodium falciparum malaria in a traveller returning from Ethiopia. Malar J 2021; 20: 145
• 5 Parr JB, Verity R, Doctor SM. et al Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey. J Infect Dis 2017; 216: 36-44
• 6 Plucinski MM, Herman C, Jones S. et al Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay. J Infect Dis 2019; 219: 437-447
• 7 Feleke SM, Mohammed Reichert EN. et al Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia. Nat Microbiol 2021; 06: 1289-1299
• 8 World Health Organization. Malaria Threats Maps. Im Internet www.who.int/teams/global-malaria-programme/surveillance/malaria-threats-map
• 9 Sinka ME, Pironon S, Massey NC. et al A new malaria vector in Africa: Predicting the expansion range of Anopheles stephensi and identifying the urban populations at risk. Proc Natl Acad Sci U S A 2020; 117: 24900-24908
• 10 Kweka EJ. Anopheles stephensi: a guest to watch in urban Africa. Trop Dis Travel Med Vaccines 2022; 08: 7
• 11 Takken W, Lindsay S. Increased Threat of Urban Malaria from Anopheles stephensi Mosquitoes, Africa. Emerg Infect Dis 2019; 25: 1431-1433
• 12 Chiodini PL, Patel D, Goodyer L, Ranson H.. Guidelines for malaria prevention in travellers from the United Kingdom 2021. London: Public Health England; March 2021: 172
• 13 Fradin MS.. Insect Protection. In: Keystone JS, Kozarsky PE, Connor BA, Nothdurft HD, Mendelson M, Leder K (eds.). Travel Medicine. 4th ed.: Elsevier. 2019: 43-52
• 14 The Medical Letter Inc. Insect Repellents. Insect Repellents. The Medical Letter on Drugs and Therapeutics. 2019: 61 (Issue 1579)
• 15 Stanczyk NM, Behrens RH, Chen-Hussey V. et al Mosquito repellents for travellers. BMJ 2015; 350: h99
• 16 Lupi E, Hatz C, Schlagenhauf P. The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. – a literature review. Travel Med Infect Dis 2013; 11: 374-411
• 17 DTG. Ständiger Ausschuss für Reisemedizin (StAR) der DTG. Im Internet https://dtg.org/index.php/ueber-die-dtg/ausschuesse/reisemedizin.html
• 18 Vinnemeier CD, Rothe C, Kreuels B. et al Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study. Malar J 2017; 16: 44
• 19 Tan R, Elmers J, Genton B. Malaria standby emergency treatment (SBET) for travellers visiting malaria endemic areas: a systematic review and meta-analysis. J Travel Med 2019; 26: taz027
• 20 Ferrara P, Masuet-Aumatell C, Agüero F. et al The use of stand-by emergency treatment (SBET) for malaria in travellers: A systematic review and meta-analysis of observational studies. J Infect 2018; 77: 455-462
• 21 Ferrara P, Masuet-Aumatell C, Agüero F. et al Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study. Malar J 2018; 17: 134
• 22 Schlagenhauf P, Wilson ME, Petersen E, McCarthy A, Chen LH.. Malaria Chemoprophylaxis. In: Keystone JS, Kozarsky PE, Connor BA, Nothdurft HD, Mendelson M, Leder K (eds.). Travel Medicine. 4th ed.: Elsevier. 2019: 145-167
• 23 Gaillard T, Briolant S, Madamet M. et al The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J 2017; 16: 148
• 24 Chelapharm. Educational Material Lariam. Österreich – Behördlich beauftragtes Schulungsmaterial für medizinisches Fachpersonal für Lariam 250 mg, Tablette. Im Internet https://www.cheplapharm.com/educational-material/lariam/
• 25 Adamcova M, Schaerer MT, Bercaru I. et al Eye disorders reported with the use of mefloquine (Lariam) chemoprophylaxis – A drug safety database analysis. Travel Med Infect Dis 2015; 13: 400-408
• 26 Kurth F, Develoux M, Mechain M. et al Severe malaria in Europe: an 8-year multi-centre observational study. Malar J 2017; 16: 57
• 27 Health Belgium. Avis 9158 patients ID et vaccination. 09/10/2019. Im Internet www.health.belgium.be/fr/avis-9158-patients-id-et-vaccination
• 28 Kurth F, Lingscheid T, Steiner F. et al Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria. Emerg Infect Dis 2016; 22: 1381-1386
• 29 Froeschl G, Nothdurft HD, von Sonnenburg F. et al Retrospective clinical case series study in 2017 identifies Plasmodium knowlesi as most frequent Plasmodium species in returning travellers from Thailand to Germany. Euro Surveill 2018; 23: 1700619
• 30 Schwartz E, Parise M, Kozarsky P. et al Delayed onset of malaria – implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349: 1510-1516
• 31 Baird JK. Tafenoquine for travelers’ malaria: evidence, rationale and recommendations. J Travel Med 2018; 25: tay110
• 32 Pays JF. Threats to the Effectiveness of Malaria Treatment. Bull Soc Pathol Exot 2018; 111: 197-198
• 33 Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet 2018; 391: 1608-1621
• 34 Grobusch MP, Kremsner PG. Uncomplicated malaria. Curr Top Microbiol Immunol 2005; 295: 83-104
• 35 Wilson ME, Weld LH, Boggild A. et al Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44: 1560-1568
• 36 DTG. Leitlinie: Diagnostik und Therapie der Malaria. Version Februar 2021. Im Internet https://www.awmf.org/uploads/tx_szleitlinien/042-001l_S1_Diagnostik-Therapie-Malaria_2021-08.pdf
• 37 Froeschl G, Beissner M, Huber K. et al Plasmodium knowlesi infection in a returning German traveller from Thailand: a case report on an emerging malaria pathogen in a popular low-risk travel destination. BMC Infect Dis 2018; 18: 148
• 38 Bundesamt für Gesundheit (BAG) und Expertenkomitee für Reisemedizin (EKRM). Malariaschutz für Kurzzeitaufenthalter (Reisen bis zu 3 Monaten). BAG; Januar 2016: 24
• 39 Albright TA, Binns HJ, Katz BZ. Side effects of and compliance with malaria prophylaxis in children. J Travel Med 2002; 09: 289-292
• 40 Emryotox.de. Doxycyclin. Im Internet https://www.embryotox.de/arzneimittel/details/doxycyclin/
• 41 HIV Drug interactions. Im Internet www.hiv-druginteractions.org
• 42 Infrastruktur BfVud (ed.). Seeärztlicher Dienst DSBV Malaria-Merkblatt. Hamburg. 2018: 8
• 43 World Health Organization. International Medical Guide for Ships. 3rd ed. 2007. Im Internet https://apps.who.int/iris/bitstream/handle/10665/43814/9789240682313_eng.pdf?sequence=1
• 44 von Seidlein L. The Advanced Development Pathway of the RTS,S/AS01 Vaccine. Methods Mol Biol 2019; 2013: 177-187
• 45 World Health Organization Malaria vaccine: WHO position paper - March 2022. Wkly Epid Re 2022; 97: 61-80
• 46 Mordmuller B, Supan C, Sim KL. et al Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J 2015; 14: 117
• 47 Mordmuller B, Surat G, Lagler H. et al Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 2017; 542: 445-449
• 48 Lyke KE, Ishizuka AS, Berry AA. et al Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A 2017; 114: 2711-2716
• 49 Mordmuller B, Sulyok M, Egger-Adam D. et al First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria. Clin Infect Dis 2019; 69: 1509-1516